Amkay Products Ltd Stock Price Today (NSE: AMKAY)
Fundamental Score
Amkay Products Ltd Share Price Live NSE/BSE & Institutional Fundamental Analysis
Amkay Products Ltd share price today is ₹56.68, up +0.00% on NSE/BSE as of 6 March 2026. Amkay Products Ltd (AMKAY) is a Small-cap company in the Medical Equipment & Supplies sector with a market capitalisation of ₹39.82 (Cr). The 52-week high for AMKAY share price is ₹N/A and the 52-week low is ₹N/A. At a P/E ratio of 11.44x, AMKAY is currently trading below its industry average P/E of 47.87x. The company has a Return on Equity (ROE) of 14.79% and a debt-to-equity ratio of 0.07.
Amkay Products Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Amkay Products Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Amkay Products Share Price Analysis: ROCE-Driven Efficiency
In the Medical Equipment & Supplies sector, a critical, often overlooked, success factor is the efficient deployment of capital. Companies that maximize returns on their capital investments demonstrate superior operational capabilities and often achieve higher valuations. This analysis focuses on Amkay Products share price, currently trading at ₹60.20, with a Price-to-Earnings (PE) ratio of 11.44 and a Return on Capital Employed (ROCE) of 16.88%. This report is part of a broader, 80-parameter fundamental audit verified by Sweta Mishra.
A key metric for assessing financial health, ROCE indicates how effectively a company utilizes its capital to generate profits. Amkay Products' ROCE of 16.88% suggests relatively sound capital allocation compared to the broader market. This figure, however, should be benchmarked against its sector peers to determine relative strength. While a direct comparison requires access to the latest ROCE figures for companies like Choksi Asia, OSEL DEVICES LIMITED, and Transpact Enterprises Ltd, the 16.88% figure provides a useful starting point for investigation.
The strength of ROCE significantly impacts a company’s economic moat, its ability to maintain competitive advantages over long periods. A higher ROCE suggests efficient operations, possibly stemming from strong brand recognition, cost advantages, or switching costs. A sustained high ROCE often indicates a durable competitive edge that protects profits from competitors. In comparison to
Choksi Asia, differences in ROCE might indicate varying levels of management effectiveness or differing strategic choices regarding capital investment. For example, disparities in ROCE, when viewed alongside publicly available information, could potentially reflect more conservative or aggressive reinvestment policies.The PE ratio of 11.44 suggests that the market currently prices Amkay Products at a relatively conservative level compared to its earnings. However, understanding the sustainability of the 16.88% ROCE is crucial. Future earnings growth and the ability to maintain a high ROCE will ultimately determine the long-term trajectory of Amkay Products share price. Monitoring these metrics over time will provide insights into the company's ability to create and sustain shareholder value.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Amkay Products Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of AMKAY across key market metrics for learning purposes.
Positive Indicators
8 factors identified
Excellent ROCE Performance (16.88%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Attractive Valuation (P/E: 11.44 vs Industry: 47.87)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Strong Revenue Growth (28.98%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Strong Profit Growth Track Record (39.33% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Conservative Debt Levels (D/E: 0.07)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (12.23x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Balanced Promoter Holding (73.44%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
3 factors identified
Weak Earnings Growth (-55.84% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Negative Free Cash Flow (₹-7.28 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Amkay Products Ltd Financial Statements
Comprehensive financial data for Amkay Products Ltd including income statement, balance sheet and cash flow
About AMKAY (Amkay Products Ltd)
Amkay Products Ltd (AMKAY) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Medical Equipment & Supplies sector with a current market capitalisation of ₹39.82 (Cr). Amkay Products Ltd has delivered a Return on Equity (ROE) of 14.79% and a ROCE of 16.88%. The debt-to-equity ratio stands at 0.07, reflecting the company's capital structure. Investors tracking AMKAY share price can monitor key metrics including P/E ratio, promoter holding of 73.44%, and quarterly earnings growth.
Company Details
Key Leadership
Latest News
AMKAY Share Price: Frequently Asked Questions
What is the current share price of Amkay Products Ltd (AMKAY)?
As of 06 Mar 2026, 09:56 am IST, Amkay Products Ltd share price is ₹56.68. The AMKAY stock has a market capitalisation of ₹39.82 (Cr) on NSE/BSE.
Is AMKAY share price Overvalued or Undervalued?
AMKAY share price is currently trading at a P/E ratio of 11.44x, compared to the industry average of 47.87x. Based on this relative valuation, the Amkay Products Ltd stock appears to be Undervalued against its sector peers.
What is the 52-week high and low of AMKAY share price?
The 52-week high of AMKAY share price is ₹N/A and the 52-week low is ₹N/A.
What factors affect the Amkay Products Ltd share price?
Key factors influencing AMKAY share price include quarterly earnings growth (Sales Growth: 28.98%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Amkay Products Ltd a good stock for long-term investment?
Amkay Products Ltd shows a 5-year Profit Growth of 39.33% and an ROE of 14.79%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.07 before investing in AMKAY shares.
How does Amkay Products Ltd compare with its industry peers?
Amkay Products Ltd competes with major peers in the Medical Equipment & Supplies. Investors should compare AMKAY share price P/E of 11.44x and ROE of 14.79% against the industry averages to determine competitive standing.
What is the P/E ratio of AMKAY and what does it mean?
AMKAY share price has a P/E ratio of 11.44x compared to the industry average of 47.87x. Investors pay ₹11 for every ₹1 of annual earnings.
How is AMKAY performing according to Bull Run's analysis?
AMKAY has a Bull Run fundamental score of 55.9/100, indicating moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does AMKAY belong to?
AMKAY operates in the Medical Equipment & Supplies industry. This classification helps understand the competitive landscape and sector-specific trends affecting Amkay Products Ltd share price.
What is Return on Equity (ROE) and why is it important for AMKAY?
AMKAY has an ROE of 14.79%, which shows decent profitability but room for improvement. ROE measures how efficiently Amkay Products Ltd generates profits from shareholders capital.
How is AMKAY debt-to-equity ratio and what does it indicate?
AMKAY has a debt-to-equity ratio of 0.07, which indicates conservative financing with low financial risk.
What is AMKAY dividend yield and is it a good dividend stock?
AMKAY offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Amkay Products Ltd shares.
How has AMKAY share price grown over the past 5 years?
AMKAY has achieved 5-year growth rates of: Sales Growth 7.77%, Profit Growth 39.33%, and EPS Growth -55.84%.
What is the promoter holding in AMKAY and why does it matter?
Promoters hold 73.44% of AMKAY shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Amkay Products Ltd.
What is AMKAY market capitalisation category?
AMKAY has a market capitalisation of ₹40 crores, placing it in the Small-cap category.
How volatile is AMKAY stock?
AMKAY has a beta of N/A. A beta > 1 suggests the Amkay Products Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is AMKAY operating profit margin trend?
AMKAY has a 5-year average Operating Profit Margin (OPM) of 10.07%, indicating the company's operational efficiency.
How is AMKAY quarterly performance?
Recent quarterly performance shows Amkay Products Ltd YoY Sales Growth of 28.98% and YoY Profit Growth of 7.65%.
What is the institutional holding pattern in AMKAY?
AMKAY has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the Amkay Products Ltd stock.